Skip to content
We train early-career investigators in the methodologies and approaches needed for scientific careers in molecular and translational rheumatology.
Our two-year clinical program offers T32-sponsored options for additional years of research training.
Dr. Elana Bernstein's work advancing the care of patients with Scleroderma.
Researchers at Columbia University College of Physicians and Surgeons in New York City recently presented findings at the American College of Rheumatology’s Annual Meeting in Boston.